EULAR

Showing 3 posts of 3 posts found.

celgene_1_02

Celgene showcases strong Otezla data in psoriatic arthritis

June 13, 2018
Research and Development Celgene, EULAR, otezla, pharma

Celgene has seized the opportunity at the Annual European Congress of Rheumatology in Amsterdam to reveal positive new data for …

gsk_l_rgb

Interview: GSK’s subcutaneous formulation for Benlysta may help cut down hospital visits

June 22, 2016
Research and Development Benlysta, EULAR, Interview, Lupus, NICE, autoimmune diseases, drug trial

UK drugmaker GlaxoSmithKine (LSE: GSK) reported positive results for Benlysta following a late-stage study at the annual European Congress of …

Hospira image

Data supports switching to Hospira biosimilar for RA

June 10, 2015
Research and Development, Sales and Marketing EULAR, Hospira, Janssen, RA, brett wells, celltrion, inflectra, rome

Findings presented at EULAR this week from the first real-world study in patients with rheumatic diseases supports switching from J&J’s …

Latest content